Vietnam says panel recommends Sputnik V, Moderna vaccines for use




  • In US
  • 2021-02-26 10:30:20Z
  • By Reuters

HANOI/MOSCOW (Reuters) - Vietnam plans to acquire 150 million doses for its COVID-19 vaccination programme, as the health ministry said a medical panel had recommended it approve Russia's Sputnik V vaccine and the Moderna vaccine for use in the Southeast Asian country.

The 150 million doses will include both those directly purchased and doses obtained via the COVAX vaccine-sharing scheme, according to a ruling posted on the government's website.

On Wednesday, Vietnam received its first batch of 117,000 doses of the AstraZeneca vaccine ahead of the planned rollout of its inoculation programme from next month.

Russia's Interfax news agency reported on Friday the Sputnik V vaccine had been approved, though Vietnam's health ministry said that a medical panel had recommended it and the U.S. Moderna Inc vaccine for use.

Approval by the health ministry is needed for the purchase and use of vaccines in the country. Vietnam approved the AstraZeneca vaccine late last month.

Foreign Ministry spokeswoman Le Thi Thu Hang said that the health ministry and businesses were in talks to buy more vaccines, including Sputnik V and the Pfizer-BioNTech vaccine.

"Vietnam wishes to have access to sources of quality COVID-19 vaccines at reasonable prices and suitable for Vietnam's storage conditions," Hang told a news conference on Thursday.

The government ruling said frontline workers, security forces, diplomats, teachers and people of 65 or older will be among the first to be inoculated, for free.

Vietnam was lauded globally for its record in containing the virus for long spells last year through mass testing and tracing and strict quarantining, though it has faced a recent wave of infections.

The country has recorded 827 new COVID-19 cases since the latest outbreak started last month, or about a third of its overall caseload of 2,421 infections. It has reported just 35 deaths due to the virus.

(Reporting by Khanh Vu and Phuong Nguyen in Hanoi and Anton Kolodyazhnyy in Moscow; Editing by Jacqueline Wong and Ed Davies)

COMMENTS

More Related News

Italy reports 358 coronavirus deaths on Monday, 9,789 new cases
Italy reports 358 coronavirus deaths on Monday, 9,789 new cases
  • US
  • 2021-04-12 16:25:37Z

Italy reported 358 coronavirus-related deaths on Monday against 331 the day before, the health ministry said, while the daily tally of new infections fell to...

The leader of Sicily in Italy said as many as 80% of people are turning down the AstraZeneca jab
The leader of Sicily in Italy said as many as 80% of people are turning down the AstraZeneca jab

The shot is recommended in Italy for people over 60. Fears about the AstraZeneca vaccine are "understandable, but unjustified," one official said.

China
China's Sinovac vaccine is 50.7% effective against COVID-19, just reaching the threshold to be a vaccine worth using, a major trial showed

Sinovac's CoronaVac was more than 50% effective - the threshold above which the WHO considers a vaccine worth using.

Cameroon receives 200,000 doses of Sinopharm COVID-19 vaccine
Cameroon receives 200,000 doses of Sinopharm COVID-19 vaccine
  • US
  • 2021-04-11 19:12:43Z

Cameroon took delivery on Sunday of 200,000 doses of China's Sinopharm COVID-19 vaccines, the first vaccines to arrive in the country, which will enable it...

Pfizer vaccine may be less effective against South African and UK coronavirus variants, according to Israeli study
Pfizer vaccine may be less effective against South African and UK coronavirus variants, according to Israeli study

The study suggests that the Pfizer vaccine is less effective against two variants, though both were quite rare in Israel. It has yet to be peer reviewed.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US